December 3rd, 2026: The Cost of Not Screening for CKD & Empowering HCPs to Screen, Identify, and Act on Early-Stage CKD

December 3, 2026

Welcome to the fourth session of this ECHO program!


Claiming Credit 
Thank you for attending the session on December 3, 2026. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page

Target Audience:
This ECHO® series is designed for Primary Care Physicians, Cardiologists, Nephrologists, NPs, PAs, Pharmacists, and Nurses. Teams and individual healthcare professionals are welcome to attend!

Learning Objectives:
At the conclusion of this learning activity, participants will be better able to:

  • Integrate guideline-directed CKD testing using eGFR and uACR testing for people with T2D, hypertension, or other risk factors for CKD
  • Identify ways to improve clinician collaboration related to the management of their patients with cardiovascular-kidney-metabolic conditions

Grantor Acknowledgement:
This activity is supported by an independent medical education grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Course summary

Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
  • 1.00 Participation
Course opens: 
12/03/2026
Course expires: 
12/03/2027
Event starts: 
12/03/2026 - 7:00pm EST
Event ends: 
12/03/2026 - 8:00pm EST
Rating: 
0
Didactic Speaker

 
 
 
 
 
 

Dr. Vassalotti is a Clinical Professor of Medicine in the Division of Nephrology at the Icahn School of Medicine at Mount Sinai and the Chief Medical Officer of the National Kidney Foundation. His academic expertise focuses on primary care and population health for chronic kidney disease (CKD), emphasizing lifestyle interventions, the use of kidney- and cardioprotective medications and interdisciplinary care.

Dr. Vassalotti led the development of the Kidney Health Evaluation for Adults with Diabetes quality measure, which advances evidence-based CKD testing by incorporating estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) for detection, risk stratification, and targeted interventions. He also served as the principal investigator for an AARP-funded Quality Measures Innovation grant, evaluating the impact of Kidney Health Evaluation testing on CKD detection, treatment, and health equity. The Kidney Health Evaluation is included in commercial, Medicare and Medicaid quality metrics. Currently, he is a co-investigator for the CDC’s Kidney Disease Surveillance System. These and other collaborative efforts have resulted in over 150 publications in peer-reviewed journals.

In addition to his research and care implementation work, Dr. Vassalotti maintains an active clinical practice, seeing approximately 40 patients weekly, including local, regional, international, and second-opinion consultations. He also clinically supervises nephrology fellows and other trainees. Dr. Vassalotti prioritizes individualized patient engagement, empowering people living with kidney disease to embrace healthier lifestyles to achieve better health outcomes and fuller lives.

Hub Team Faculty

Program Chair

Nicolas Cuttriss, MD, MPH, FAAP

Pediatric Endocrinologist

Founding Director & CEO

ECHO Diabetes Action Network

 

Hub Team Activity Planners

Abinash P Achrekar, MD, MPH

Former Executive Vice Chair of Medicine

Professor of Medicine

Division of Cardiology

University of New Mexico

 

Nayan Arora, MD, FASN

Associate Professor of Medicine

Associate Director Nephrology Fellowship Program

Division of Nephrology and Hypertension

Oregon Health and Science University

 

 

Phyllisa Deroze, PhD

Founder, Black Diabetic Info

Pompano Beach, FL

 

 

Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM 

Clinical Pharmacy Specialist – Endocrinology 

Certified Diabetes Care and Education Specialist 

Boston Medical Center 

 

Jay H. Shubrook DO FACOFP, FAAFP 

Professor & Diabetologist 

Department of Clinical Sciences & Community Health 

Diabetes Institute 

Touro University California 

 

Lisa M. Taylor, DNP, MSN, FNP-BC, MPH

Associate Clinical Professor

Director of Diversity, Equity, and Inclusion

University of New Mexico College of Nursing

 

 

Boston University Center for Continuing Education Planning Team

Linda Baer, MSPH, CHCP, Associate Director

Michael Burk, BS, Senior Program Manager

 

Med-IQ Planning Team

Amy Woodward Corum, Grant Development Director

Ali Mayhew, BA, Senior Project Manager

Jaime Symowicz, PhD, Clinical Education and Strategy Manager

 

Disclosure Policy

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Accreditation Statement

This activity is developed as joint collaboration among Boston University Chobanian & Avedisian School of Medicine, ECHO Diabetes Action Network, and Med-IQ.

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Family Practitioner Accreditation
The AAFP has reviewed From Risk to Action: Improving CKD Outcomes Through a Collaborative Care ECHO® and deemed it acceptable for AAFP credit. Term of approval is from XXX to XXX Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This session From Risk to Action: Improving CKD Outcomes Through a Collaborative Care ECHO® is approved for XXX online AAFP Prescribed credits.

 

American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
 

Nurse Accreditation
Nursing Contact Hours: 1.0
 

 

Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.

 

 

Physician Associate Accreditation

Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

 

 

IPCE Accreditation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

 

Questions: If you have any questions about the program, registering or claiming credit please write [email protected] and your questions will be answered. 

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
  • 1.00 Participation
Please login or register to take this course.